3,4-methylenedioxyamphetamine has been researched along with Diabetes Mellitus, Adult-Onset in 3 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Naqvi, JB | 1 |
Liu, RS | 1 |
Helgeson, VS | 1 |
Hamm, ME | 1 |
Fallon, A | 1 |
Dunne, F | 1 |
Grossman, JB | 1 |
1 review available for 3,4-methylenedioxyamphetamine and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Breastfeeding practices that support women with diabetes to breastfeed.
Topics: Breast Feeding; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; | 2015 |
2 other studies available for 3,4-methylenedioxyamphetamine and Diabetes Mellitus, Adult-Onset
Article | Year |
---|---|
Intrusive social support among Black and White individuals with type 2 diabetes: A "Control issue" or a sign of "Concern and love"?
Topics: Black or African American; Chronic Disease; Diabetes Mellitus, Type 2; Humans; Love; Social Support; | 2023 |
Is food love?
Topics: Diabetes Mellitus, Type 2; Glycemic Index; Health Education; Health Knowledge, Attitudes, Practice; | 2007 |